Mhervin Dagdagan
Payments from drug & device makers
Across 151 payments — averaging $21.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$652
- AbbVie$490
- Neurocrine Biosciences, Inc.$303
- SK Life Science, Inc.$287
- Pfizer$274
- Lilly USA, LLC$260
- plus $1K from 14 others
What the payments were for
- Food & beverage$3,277100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 37 | $652 |
| AbbVie | 23 | $490 |
| Neurocrine Biosciences, Inc. | 12 | $303 |
| SK Life Science, Inc. | 13 | $287 |
| Pfizer | 16 | $274 |
| Lilly USA, LLC | 7 | $260 |
| Catalyst Pharmaceuticals, Inc. | 7 | $194 |
| Argenx US, Inc. | 6 | $170 |
| Lundbeck LLC | 6 | $111 |
| Amneal Pharmaceuticals LLC | 4 | $104 |
| AstraZeneca | 4 | $80 |
| Tanabe Pharma America, Inc. | 3 | $70 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| Neurelis, Inc. | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Eisai Inc. | 2 | $34 |
| Averitas Pharma Inc. | 1 | $26 |
| Grifols USA, LLC | 1 | $25 |
| Jazz Pharmaceuticals Inc. | 1 | $25 |
| Johnson & Johnson | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KISUNLA$120
How this compares
$3,277 in reported general payments places this provider in the 85th percentile of 1,501 family providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Divalproex Sodium ErDivalproex Sodium | 29 | $544 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 17 | $347 |
| Gabapentin | 35 | $321 |
| Duloxetine Hcl | 12 | $190 |
| Pregabalin | 13 | $171 |
Paid to pharmacies, not to this prescriber.
Other family in Reno
- Lisa Hammargren-KuykendallReno$22K
- Martha AiyukReno$15K
- Jocelyn AllenReno$12K
- Kaylie HumphreysReno$11K
- Christina KrainbrinkReno$10K
- Barbara SzatkowskiReno$10K
- Johanna LeeReno$9K
- Darin OldeReno$9K
- Ruth SkinnerReno$8K
- Anna EllisReno$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.